ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,488 | -58.3% | 19,496 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $41,916 | +10.3% | 19,496 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $38,017 | -49.2% | 19,496 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $74,865 | -20.4% | 19,496 | -0.0% | 0.00% | -50.0% |
| Q3 2022 | $94,000 | -39.4% | 19,502 | +0.0% | 0.00% | -20.0% |
| Q2 2022 | $155,000 | -45.8% | 19,497 | +0.1% | 0.01% | -54.5% |
| Q1 2022 | $286,000 | -27.4% | 19,469 | -0.2% | 0.01% | -31.2% |
| Q4 2021 | $394,000 | -25.7% | 19,505 | -0.0% | 0.02% | -33.3% |
| Q3 2021 | $530,000 | +11.6% | 19,514 | +0.0% | 0.02% | +9.1% |
| Q2 2021 | $475,000 | -0.2% | 19,507 | +0.0% | 0.02% | -12.0% |
| Q1 2021 | $476,000 | – | 19,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $9,430,000 | 5.29% |
| GCM Grosvenor Holdings, LLC | 1,298,012 | $10,319,000 | 2.33% |
| Redmile Group, LLC | 7,512,029 | $59,721,000 | 2.28% |
| MPM BioImpact LLC | 334,384 | $2,658,000 | 0.74% |
| Indie Asset Partners, LLC | 93,989 | $747,000 | 0.66% |
| Eventide Asset Management | 1,879,959 | $14,946,000 | 0.32% |
| Walleye Capital LLC | 888,700 | $7,065,000 | 0.20% |
| Endurant Capital Management LP | 58,967 | $469,000 | 0.16% |
| HHLR ADVISORS, LTD. | 500,000 | $3,975,000 | 0.08% |
| Matrix Capital Management Company, LP | 400,000 | $3,180,000 | 0.07% |